John Martin Overview

  • Investor Type
  • Angel
  • Investments
  • 4
  • Portfolio
  • 1
  • Exits
  • 3
Exits

John Martin General Information

Description

Dr. John Martin served as the Chairman at Arresto BioSciences. He served as the Chairman and Executive Chairman and Director at Gilead Sciences. He served as President and Chief Executive Officer from 1996 through May 2008. Prior to joining Gilead, Dr. Martin held several leadership positions at Bristol-Myers Squibb and Syntex Corporation. Dr. Martin is a member of the Board of Directors of the California Healthcare Institute. He also serves on the University of Southern California Board of Trustees. Dr. Martin previously served as President of the International Society for Antiviral Research, Chairman of the Board of Directors of BayBio and Chairman of the Board of Directors of the California Healthcare Institute. He served on the National Institute of Allergy & Infectious Diseases Council, the Board of Directors of the Biotechnology Industry Organization, the Board of Trustees of the University of Chicago, the Board of Trustees of Golden Gate University and the External Scientific Advisory Board of the University of California School of Global Health. Additionally, Dr. Martin served on the Centers for Disease Control/Health Resources and Services Administration's Advisory Committee on HIV and STD Prevention and Treatment and was a member of the Presidential Advisory Council on HIV/AIDS. Dr. Martin holds a PhD in organic chemistry from the University of Chicago and an MBA in marketing from Golden Gate University. He has received the Isbell Award from the American Chemical Society and the Gertrude B. Elion Award for Scientific Excellence from the International Society for Antiviral Research. In 2008, Dr. Martin was inducted into the National Academy of Engineering of the National Academies. He serves as a Board Member at Kronos Bio. He serves as Board Member at Sarepta Therapeutics.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • 1300 South El Camino Real
  • Suite 300
  • San Mateo, CA 94402
  • United States
+1 (650) 000-0000

John Martin Investments (4)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
School Day 12-May-2020 Seed Round 00.00 Educational and Training Services (B2C) Generating Revenue 0000 000000 00.0
000000 000 13-Jul-2019 00000 00000 00000 Biotechnology Pre-Clinical Trials 0000 000000 00.0
Kronos Bio 23-May-2018 Seed Round 0000 Biotechnology Pre-Clinical Trials 0000 000000 00.0
Bluesmart 01-Sep-2014 Seed Round 00000 Electronics (B2C) Generating Revenue/Not Profitable
To view John Martin’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

John Martin Exits (3)

Company Name Exit Date Exit Type Exit Size
Kronos Bio 09-Oct-2020 IPO 00000
000000000 03-May-2018 0000000000
000000000 02-May-2018 0000000000: 000000
To view John Martin’s complete exits history, request access »

John Martin Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

John Martin Team (1)

Name Title Deals Funds Boards Office
John Martin Ph.D Angel Investor 0 0 Palo Alto, CA
To view John Martin’s complete team members history, request access »

John Martin Co-Investors (12)

Name With Exits Lead Partner Series Industry
GV 1 0 Series chart Industry bar
Nextech Invest 0 0 Series chart Industry bar
Omega Funds 0 0 Series chart Industry bar
Polaris Partners 0 0 Series chart Industry bar
The Invus Group 0 0 Series chart Industry bar
You’re viewing 5 of 12 co-investors. Get the full list »